In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years-Reference-Cited by-同舟云学术

In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years

Published:2008-06 Issue:6 Volume:52 Page:2226-2227
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Huang Tsi-Shu¹²³,Liu Yung-Ching¹³,Sy Cheng-Len⁴,Chen Yao-Shen⁴⁵,Tu Hui-Zin¹,Chen Bao-Chen¹

Affiliation:

1. Section of Microbiology, Dept. of Pathology and Laboratory Medicine

2. Department of Medical Technology, Foo-Yin Institute of Technology, Kaohsiung, Taiwan

3. School of Medicine, National Yang-Ming University, Taipei, Taiwan

4. Section of Infectious Diseases, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

5. Graduate Institute of Environmental Education, National Kaohsiung Normal University, Kaohsiung, Taiwan

Abstract

ABSTRACT Significant increases in the MIC 90 s of linezolid in multidrug-resistant Mycobacterium tuberculosis isolates were seen between the baseline period of 2001 to 2003 (0.5 μg/ml) and 2004 (2 μg/ml). The MICs were 4 μg/ml in three strains. Both fluoroquinolones (except levofloxacin) and kanamycin were found to have statistically significant degrees of concordance with linezolid.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00414-07

Reference11 articles.

1. In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous Drugs

2. Statistics of communicable diseases and surveillance report in Taiwan area 2003 2004

3. Escribano, I., J. C. Rodriguez, B. Llorca, E. Garcia-Pachon, M. Ruiz, and G. Royo. 2007. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy53:397-401.

4. Hilderand, D. K., J. D. Laingand, and H. Rosenthal. 1977. Prediction analysis of cross classifications, p. 55-56. In J. Neter, W. Wasserman, and G. G. Whitmore (ed.), Applied statistics. John Wiley & Sons, New York, NY.

5. Hsueh, P. R., Y. C. Liu, J. So, C. Y. Liu, P. C. Yang, and K. T. Luh. 2006. Mycobacterium tuberculosis in Taiwan. J. Infect.52:77-85.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-08

2. Designing molecular diagnostics for current tuberculosis drug regimens;Emerging Microbes & Infections;2023-02-27

3. Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-08-30

4. Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains;Journal of Medicinal Chemistry;2021-04-07

5. A New Class of Linezolid‐Based Molecules as Potential Antimicrobial and Antitubercular Agents: A Rational Approach;ChemistrySelect;2021-04